Receptor-binding antiproliferative peptides
US5512435A · kind A · utility
Inventors
Key dates
| Filing date | Feb 5, 1993 |
| Grant date | Apr 30, 1996 |
| Priority date | — |
| Expiry date | Feb 5, 2013 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/965
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Methods and composition are provided for identifying antiproliferative polypeptides which inhibit clonal expansion and/or induce apoptosis in cells of a predetermined cell population (e.g., a neoplastic cell sample) expressing a cell surface receptor which is a member of the immunoglobulin superfamily. A predetermined cell population expressing surface immunoglobulin superfamily molecules is isolated from a patient as a cellular sample, such as a lymph node biospy or blood sample containing neoplastic lymphocytic cells. Antiproliferative peptides which are identified by the methods of the invention can be used as therapeutic agents for treating lymphoproliferative disorders by anti-idiotype therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.